Five Star Equities releases regular market updates so investors can stay ahead of the crowd and make the best investment decisions to maximize their returns. Take a few minutes to register with us free at www.FiveStarEquities.com and get exclusive access to our numerous stock reports.
Digital Power Corporation (NYSEMKT: DPW) shares surged 44.51 percent to close at $2.24 a share Wednesday. The stock traded between $1.59 and $3.05 on volume 4.61 million shares traded. The company announced that it has been awarded a 5-year military contract for the Israel Aerospace Industry. Shares of Digital Power are up approximately 235.0 percent year-to-date.
Get more information on Digital Power free access to the in-depth equity report at:
www.FiveStarEquities.com/DPW
IsoRay, Inc. (NYSEMKT: ISR) shares soared 133.94 percent to close at $2.55 a share Wednesday. The stock traded between $1.09 and $3.04 on volume of 87.09 million shares traded. The company announced that the first pediatric patient's tumor was treated with Cesium-131 sutured seed meshes for internal radiation therapy. Shares of IsoRay are up over 400.0 percent year-to-date.
Get more information on IsoRay and free access to the in-depth equity report at:
www.FiveStarEquities.com/ISR
Prothena Corporation PLC (NASDAQ: PRTA) shares spiked 27.53 percent to close at $47.39 a share Wednesday. The stock traded between $43.76 and $47.49 on volume of 1.94 million shares traded. The company announced that clinical data from its ongoing Phase 1 study of NEOD001 in patients with immunoglobulin light chain (AL) amyloidosis and persistent organ dysfunction will be presented at the XIV International Symposium. Shares of Prothena are up approximately 78.0 percent year-to-date.
Get more information on Prothena and free access to the in-depth equity report at:
www.FiveStarEquities.com/PRTA
TherapeuticsMD Inc. (NYSEMKT: TXMD) shares dropped 7.40 percent to close at $7.38 a share Wednesday. The stock traded between $7.00 and $7.93 on volume 1.36 million shares traded. The company announced the launch of a secondary public offering of 9.0 million shares of its common stock. Shares of TherapeuticsMD are up approximately 40.0 percent year-to-date.
Get more information on TherapeuticsMD and free access to the in-depth equity report at:
www.FiveStarEquities.com/TXMD
Disclaimer: Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. Five Star Equities has no financial relationship with any company whose stock is mentioned in this release.
Contact:
Five Star Equities
[email protected]